Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Citius Pharmaceuticals Inc (NASDAQ:CTXR) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 978.83K à 1.58M. Cela représente 8.8% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Citius Pharmaceuticals Corp (XNAS:CTXR) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 573.43K actions échangées par jour, il faudrait 2.76 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
1.58M
Intérêt à court terme %
8.80%
Jours de couverture
2.76
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CTXR | Citius Pharmaceuticals, Inc. C | 10/15/2025 | 10/24/2025 | 8.80% | 17,979,305 | 1,581,959 | 573,435 | 2.76 | |
CTXR | Citius Pharmaceuticals, Inc. C | 09/30/2025 | 10/09/2025 | 5.93% | 16,519,305 | 978,825 | 287,028 | 3.41 | |
CTXR | Citius Pharmaceuticals, Inc. C | 09/15/2025 | 09/24/2025 | 6.26% | 16,519,305 | 1,033,868 | 269,923 | 3.83 | |
CTXR | Citius Pharmaceuticals, Inc. C | 08/29/2025 | 09/10/2025 | 4.81% | 16,519,305 | 795,318 | 678,461 | 1.17 | |
CTXR | Citius Pharmaceuticals, Inc. C | 08/15/2025 | 08/26/2025 | 3.99% | 16,519,305 | 658,545 | 209,885 | 3.14 | |
CTXR | Citius Pharmaceuticals, Inc. C | 07/31/2025 | 08/11/2025 | 7.44% | 10,337,449 | 769,319 | 514,415 | 1.5 | |
CTXR | Citius Pharmaceuticals, Inc. C | 07/15/2025 | 07/24/2025 | 10.85% | 10,337,449 | 1,121,886 | 1,690,955 | 1 | |
CTXR | Citius Pharmaceuticals, Inc. C | 06/30/2025 | 07/10/2025 | 9.38% | 10,337,449 | 969,686 | 2,397,800 | 1 | |
CTXR | Citius Pharmaceuticals, Inc. C | 06/13/2025 | 06/25/2025 | 13.04% | 10,337,449 | 1,348,420 | 11,267,844 | 1 | |
CTXR | Citius Pharmaceuticals, Inc. C | 05/30/2025 | 06/10/2025 | 6.78% | 9,797,449 | 664,615 | 138,639 | 4.79 | |
CTXR | Citius Pharmaceuticals, Inc. C | 05/15/2025 | 05/27/2025 | 6.16% | 9,797,449 | 603,412 | 146,022 | 4.13 | |
CTXR | Citius Pharmaceuticals, Inc. C | 04/30/2025 | 05/09/2025 | 7.56% | 8,867,449 | 670,558 | 138,098 | 4.86 | |
CTXR | Citius Pharmaceuticals, Inc. C | 04/15/2025 | 04/25/2025 | 8.52% | 8,867,449 | 755,910 | 227,171 | 3.33 | |
CTXR | Citius Pharmaceuticals, Inc. C | 03/31/2025 | 04/09/2025 | 7.68% | 8,867,449 | 681,240 | 967,354 | 1 | |
CTXR | Citius Pharmaceuticals, Inc. C | 03/14/2025 | 03/25/2025 | 6.39% | 8,100,547 | 517,586 | 68,670 | 7.54 | |
CTXR | Citius Pharmaceuticals, Inc. C | 02/28/2025 | 03/11/2025 | 6.75% | 8,100,547 | 547,014 | 302,820 | 1.81 | |
CTXR | Citius Pharmaceuticals, Inc. C | 02/14/2025 | 02/26/2025 | 6.67% | 8,100,547 | 540,139 | 72,456 | 7.45 | |
CTXR | Citius Pharmaceuticals, Inc. C | 01/31/2025 | 02/11/2025 | 6.34% | 8,100,547 | 513,896 | 94,498 | 5.44 | |
CTXR | Citius Pharmaceuticals, Inc. C | 01/15/2025 | 01/27/2025 | 7.36% | 7,978,421 | 587,009 | 137,848 | 4.26 | |
CTXR | Citius Pharmaceuticals, Inc. C | 12/31/2024 | 01/10/2025 | 7.46% | 7,978,421 | 595,333 | 231,792 | 2.57 | |
CTXR | Citius Pharmaceuticals, Inc. C | 12/13/2024 | 12/24/2024 | 7.24% | 7,234,925 | 523,868 | 154,506 | 3.39 | |
CTXR | Citius Pharmaceuticals, Inc. C | 11/29/2024 | 12/10/2024 | 8.34% | 7,234,925 | 603,742 | 1,090,730 | 1 | |
CTXR | Citius Pharmaceuticals, Inc. C | 11/15/2024 | 11/26/2024 | — | 7,234,866 | 13,446,411 | 3,083,471 | 4.36 | |
CTXR | Citius Pharmaceuticals, Inc. C | 10/31/2024 | 11/11/2024 | 7.00% | 168,417,468 | 11,787,635 | 671,812 | 17.55 | |
CTXR | Citius Pharmaceuticals, Inc. C | 10/15/2024 | 10/24/2024 | 7.38% | 168,417,468 | 12,421,963 | 1,086,247 | 11.44 | |
CTXR | Citius Pharmaceuticals, Inc. C | 09/30/2024 | 10/09/2024 | 7.58% | 168,417,468 | 12,768,363 | 1,138,644 | 11.21 | |
CTXR | Citius Pharmaceuticals, Inc. C | 09/13/2024 | 09/24/2024 | 7.44% | 168,417,468 | 12,530,596 | 605,650 | 20.69 | |
CTXR | Citius Pharmaceuticals, Inc. C | 08/30/2024 | 09/11/2024 | 7.95% | 168,417,468 | 13,389,164 | 1,031,930 | 12.97 | |
CTXR | Citius Pharmaceuticals, Inc. C | 08/15/2024 | 08/26/2024 | 7.29% | 168,417,468 | 12,283,475 | 3,115,581 | 3.94 | |
CTXR | Citius Pharmaceuticals, Inc. C | 07/31/2024 | 08/09/2024 | 8.69% | 168,365,416 | 14,625,958 | 2,306,383 | 6.34 | |
CTXR | Citius Pharmaceuticals, Inc. C | 07/15/2024 | 07/24/2024 | 7.13% | 168,365,416 | 12,004,667 | 2,828,945 | 4.24 | |
CTXR | Citius Pharmaceuticals, Inc. C | 06/28/2024 | 07/10/2024 | 8.41% | 168,365,416 | 14,154,527 | 3,045,946 | 4.65 | |
CTXR | Citius Pharmaceuticals, Inc. C | 06/14/2024 | 06/26/2024 | 9.18% | 168,365,416 | 15,463,236 | 785,117 | 19.7 | |
CTXR | Citius Pharmaceuticals, Inc. C | 05/31/2024 | 06/11/2024 | 9.45% | 168,365,416 | 15,905,753 | 3,402,816 | 4.67 | |
CTXR | Citius Pharmaceuticals, Inc. C | 05/15/2024 | 05/24/2024 | 8.60% | 168,365,416 | 14,481,311 | 1,276,748 | 11.34 | |
CTXR | Citius Pharmaceuticals, Inc. C | 04/30/2024 | 05/09/2024 | 8.58% | 168,215,416 | 14,428,232 | 1,560,336 | 9.25 | |
CTXR | Citius Pharmaceuticals, Inc. C | 04/15/2024 | 04/24/2024 | 8.99% | 146,786,842 | 13,194,631 | 1,022,990 | 12.9 | |
CTXR | Citius Pharmaceuticals, Inc. C | 03/28/2024 | 04/09/2024 | 8.46% | 146,786,842 | 12,425,469 | 703,614 | 17.66 | |
CTXR | Citius Pharmaceuticals, Inc. C | 03/15/2024 | 03/26/2024 | 8.30% | 146,786,842 | 12,180,263 | 562,529 | 21.65 | |
CTXR | Citius Pharmaceuticals, Inc. C | 02/29/2024 | 03/11/2024 | 8.08% | 146,786,842 | 11,863,452 | 559,273 | 21.21 | |
CTXR | Citius Pharmaceuticals, Inc. C | 02/15/2024 | 02/27/2024 | 7.89% | 146,786,842 | 11,581,279 | 721,245 | 16.06 | |
CTXR | Citius Pharmaceuticals, Inc. C | 01/31/2024 | 02/09/2024 | 7.92% | 146,658,637 | 11,613,656 | 828,002 | 14.03 | |
CTXR | Citius Pharmaceuticals, Inc. C | 01/12/2024 | 01/24/2024 | 9.50% | 146,658,639 | 13,936,674 | 585,799 | 23.79 | |
CTXR | Citius Pharmaceuticals, Inc. C | 12/29/2023 | 01/10/2024 | 9.97% | 146,658,639 | 14,618,183 | 505,578 | 28.91 | |
CTXR | Citius Pharmaceuticals, Inc. C | 12/15/2023 | 12/27/2023 | 9.19% | 146,549,861 | 13,461,302 | 589,502 | 22.84 | |
CTXR | Citius Pharmaceuticals, Inc. C | 11/30/2023 | 12/11/2023 | 10.80% | 146,549,861 | 15,831,198 | 376,789 | 42.02 | |
CTXR | Citius Pharmaceuticals, Inc. C | 11/15/2023 | 11/27/2023 | 10.93% | 146,549,861 | 16,025,164 | 428,377 | 37.41 | |
CTXR | Citius Pharmaceuticals, Inc. C | 10/31/2023 | 11/09/2023 | 11.52% | 146,549,861 | 16,889,682 | 840,982 | 20.08 |
À la recherche des actions les plus vendues à découvert?